Gentis Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Out of Business

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Out of Business

Gentis General Information

Description

Provider of biomaterials-based products designed to treat the early-stage degeneration of the spine. The company's biomaterials-based product, DiscCell, is an injectable, in-situ setting, radio-opaque, non-hydrogel polymer material that augments or replaces the diseased nucleus pulposus of the spinal disc, enabling patients to prevent a recurrence of back or leg pain at the treatment site.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 400 East Lancaster Avenue
  • Suite 300
  • Wayne, PA 19087
  • United States
+1 (610)
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Corporate Office
  • 400 East Lancaster Avenue
  • Suite 300
  • Wayne, PA 19087
  • United States
+1 (610)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gentis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 01-Jun-2016 Completed Out of Business
5. Secondary Transaction - Private 01-Apr-2014 Completed Profitable
4. Later Stage VC 02-Feb-2014 Completed Profitable
3. Later Stage VC Completed Profitable
2. Later Stage VC (Series B) 19-Jul-2010 $548K $12.5M Completed Profitable
1. Later Stage VC (Series A) 22-Jun-2007 $12M $12M Completed Profitable
To view Gentis’s complete valuation and funding history, request access »

Gentis Patents

Gentis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20050112186-A1 Nontoxic, biocompatible water in oil emulsion with organic phase of ethenically unsaturated monomers or oligomers that does not provoke an autoimmune or inflammatory response for reforming damaged or diseased intervertebral discs by noninvasive means Active 29-Oct-2003
US-20070218124-A1 Nontoxic, biocompatible water in oil emulsion with organic phase of ethenically unsaturated monomers or oligomers that does not provoke an autoimmune or inflammatory response for reforming damaged or diseased intervertebral discs by noninvasive means Active 29-Oct-2003
US-20070248643-A1 Nontoxic, biocompatible water in oil emulsion with organic phase of ethenically unsaturated monomers or oligomers that does not provoke an autoimmune or inflammatory response for reforming damaged or diseased intervertebral discs by noninvasive means Active 29-Oct-2003
US-7537754-B2 Nontoxic, biocompatible water in oil emulsion with organic phase of ethenically unsaturated monomers or oligomers that does not provoke an autoimmune or inflammatory response for reforming damaged or diseased intervertebral discs by noninvasive means Inactive 29-Oct-2003
US-7651682-B2 Nontoxic, biocompatible water in oil emulsion with organic phase of ethenically unsaturated monomers or oligomers that does not provoke an autoimmune or inflammatory response for reforming damaged or diseased intervertebral discs by noninvasive means Inactive 29-Oct-2003 A61L27/26
To view Gentis’s complete patent history, request access »

Gentis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gentis FAQs

  • When was Gentis founded?

    Gentis was founded in 2000.

  • Where is Gentis headquartered?

    Gentis is headquartered in Wayne, PA.

  • What is the size of Gentis?

    Gentis has 7 total employees.

  • What industry is Gentis in?

    Gentis’s primary industry is Surgical Devices.

  • Is Gentis a private or public company?

    Gentis is a Private company.

  • What is Gentis’s current revenue?

    The current revenue for Gentis is .

  • How much funding has Gentis raised over time?

    Gentis has raised $13.3M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process